While Eli Lilly (LLY -2.39%) and Novo Nordisk (NVO +0.02%) currently dominate this area, a first-mover advantage isn't everything
Since GLP-1 medications mimic the action of a peptide produced in the GI tract, most reported mild side effects are associated with the digestive tract
The steadiness is part of why so many users report the effect as smooth rather than jarring
WL: Investigation, Data curation, Formal analysis, Methodology, Software, Validation, Writing original draft
In a previous work, using cellular models derived from PKAN patients, we confirmed the hypothesis that CoA deficiency caused by PANK2 mutations affects the expression levels and activity of key mitochondrial proteins harboring a 4-phosphopantetheinyl cofactor such as mtACP, ALDH1L2 or AASS [12]